AbbVie Earnings Preview: What to Expect

AbbVie Inc. (ABBV), a top global pharmaceutical company with a market cap of $300 billion, specializes in developing and manufacturing a wide range of therapeutic products. The North Chicago, Illinois-based company is expected to announce its fiscal Q2 earnings results before the market opens on Thursday, Jul. 25.

Ahead of this event, analysts expect the pharmaceutical giant to report a profit of $2.58 per share, down 11.3% from $2.91 per share in the year-ago quarter. The company has surpassed Wall Street's bottom-line estimates in each of the last four quarterly reports. The company reported EPS of $2.31 in the most recent quarter, exceeding the consensus estimate by 2.2% due to the strong sales performance of Skyrizi and cancer drug Imbruvica.